Markets:

Overview

News

Currencies

International

Treasuries

Replimune Group, Inc. - Common Stock (NQ:REPL)

7.180 -0.360 (-4.77%)

Streaming Delayed Price Updated: 12:52 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Replimune Group, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Which stocks are experiencing notable movement on Tuesday? ↗

July 22, 2025

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

REPL BREAKING NEWS: Replimune Group, Inc. Stock Plummets 75% after FDA Response Letter – BFA Law Announces Securities Fraud Investigation and Urges Investors to Contact the Firm

July 22, 2025

From Bleichmar Fonti & Auld LLP

Via Business Wire

Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock ↗

July 22, 2025

The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 22, 2025

Via Benzinga

Nasdaq Falls Over 100 Points; Coca-Cola Posts Upbeat Earnings ↗

July 22, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

July 22, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Rosen Law Firm Encourages Replimune Group, Inc. Investors to Inquire About Securities Class Action Investigation – REPL

July 22, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Gapping stocks in Tuesday's session ↗

July 22, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

US Stocks Mixed; General Motors Shares Fall After Q2 Results ↗

July 22, 2025

Via Benzinga

FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks ↗

July 22, 2025

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

Via Benzinga

Which stocks are moving before the opening bell on Tuesday? ↗

July 22, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

July 22, 2025

From Replimune, Inc.

Via GlobeNewswire

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 11, 2025

From Replimune, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 12, 2025

Via Benzinga

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

June 01, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune to Present at the 2025 Jefferies Global Healthcare Conference

May 29, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

May 22, 2025

From Replimune Group Inc

Via GlobeNewswire

Earnings Scheduled For May 22, 2025 ↗

May 22, 2025

Via Benzinga

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

May 16, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 09, 2025

From Replimune Group Inc

Via GlobeNewswire

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗

April 21, 2025

Via Benzinga

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 11, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 07, 2025

From Replimune Group Inc

Via GlobeNewswire

Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

February 12, 2025

From Replimune Group Inc

Via GlobeNewswire

Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 10, 2025

Via Benzinga

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

February 10, 2025

Via Benzinga

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 07, 2025

From Replimune Group Inc

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.